BioSpace News Archive

Drug Development

Alnylam Completes Enrollment in ENVISION Phase 3 Study of Givosiran, an Investigational RNAi Therapeutic for the Treatment of Acute Hepatic Porphyrias (AHPs)

Enrollment Completed Ahead of Schedule, Eight Months After First Patient Randomized

August 21, 2018
·
10 min read
Deals

MBio Diagnostics, Inc. Announces Additional $6 Million in Series B Funding

Funding Supports Scaling of Portable On-the-Spot Testing Platform

August 21, 2018
·
3 min read
Biotech Beach

Largest Brain Study of 62,454 Scans Identifies Drivers of Brain Aging

Schizophrenia, cannabis use, and alcohol abuse are just several disorders that are related to accelerated brain aging

August 21, 2018
·
5 min read
Business

Covenant Animal Health Partners Launches; Firm Will Accelerate Animal Health Products to Market

Novel Partnership Between TechAccel and Reliance Animal Health Partners Will Develop Revenue-ready Products.

August 21, 2018
·
5 min read
FDA

Audentes Announces Regenerative Medicine Advanced Therapy (RMAT) Designation Granted by the FDA to AT132 for the Treatment of X-Linked Myotubular Myopathy

Designation granted based on positive interim data from ASPIRO clinical trial

August 21, 2018
·
6 min read
Business

Lumendi Expands Team with New VP of Sales, Michael R. Thomas

Lumendi, LLC is again expanding its team as Michael R. Thomas joins as Vice President of Sales.

August 21, 2018
·
2 min read
Biotech Bay

EyeQue Expands Vision Monitoring for Consumers, Adding Color and Contrast Sensitivity Tests to Insight Vision Screener

Leader of consumer vision solutions broadens product capabilities to elevate at-home vision testing

August 21, 2018
·
4 min read
Drug Development

Dallas-Based Software Developer, DoctorLogic®, Makes the 2018 Inc. 5000 List

DoctorLogic ranks 317 out of 5,000 fastest-growing private companies with a total growth of more than 1,500% since its launch.

August 21, 2018
·
2 min read
Therabiopharma (Japan Based Bio-Venture) Reports 10,000 Times Higher Curcumin Concentration in Bloodstream Clearly Demonstrates Strong Efficacies with/without Oxaliplatin in an Animal Study for Colon Cancer

Therabiopharma reports that CMG(Curcumin Monoglucuronide) has proven Same efficacy as Oxaliplatin for colon cancer without any adverse effects observed in Oxaliplatin treatment

August 21, 2018
·
3 min read
Business

HemaCare Reports First Half 2018 Results

HemaCare Corporation announced operational highlights and financial results for the six months ended June 30, 2018.

August 21, 2018
·
6 min read